1. Targeted tuberculin testing and treatment of latent tuberculosis infection;American Thoracic Society;Am J Respir Crit Care Med,2000
2. Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations—United States, 2001;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2001
3. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection—New York and Georgia, 2000;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2001
4. Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection—United States, 2003;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2003
5. Recent developments in the treatment of tuberculosis;Davies;Expert Opin Investig Drugs,2003